Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 5
1998 1
1999 1
2000 1
2001 2
2002 1
2003 1
2004 2
2006 6
2007 2
2008 4
2009 4
2010 8
2011 4
2012 9
2013 1
2014 7
2015 7
2016 5
2017 6
2018 5
2019 6
2020 10
2021 11
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

100 results
Results by year
Filters applied: . Clear all
Page 1
Antiphospholipid syndrome.
Cuadrado MJ, Lopez-Pedrera C. Cuadrado MJ, et al. Among authors: lopez pedrera c. Clin Exp Med. 2003 Nov;3(3):129-39. doi: 10.1007/s10238-003-0016-x. Clin Exp Med. 2003. PMID: 14648227 Review.
Catastrophic antiphospholipid syndrome (CAPS).
Sciascia S, Lopez-Pedrera C, Roccatello D, Cuadrado MJ. Sciascia S, et al. Among authors: lopez pedrera c. Best Pract Res Clin Rheumatol. 2012 Aug;26(4):535-41. doi: 10.1016/j.berh.2012.07.005. Best Pract Res Clin Rheumatol. 2012. PMID: 23040365 Free article. Review.
Immunotherapy in antiphospholipid syndrome.
Lopez-Pedrera Ch, Aguirre MA, Ruiz-Limon P, Pérez-Sánchez C, Jimenez-Gomez Y, Barbarroja N, Cuadrado MJ. Lopez-Pedrera Ch, et al. Int Immunopharmacol. 2015 Aug;27(2):200-8. doi: 10.1016/j.intimp.2015.06.006. Epub 2015 Jun 15. Int Immunopharmacol. 2015. PMID: 26086363 Review.
Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome.
Sciascia S, Lopez-Pedrera C, Cecchi I, Pecoraro C, Roccatello D, Cuadrado MJ. Sciascia S, et al. Among authors: lopez pedrera c. Rheumatology (Oxford). 2016 Oct;55(10):1726-35. doi: 10.1093/rheumatology/kev445. Epub 2016 Feb 3. Rheumatology (Oxford). 2016. PMID: 26843482 Free article. Review.
Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis.
Lopez-Pedrera C, Barbarroja N, Patiño-Trives AM, Luque-Tévar M, Collantes-Estevez E, Escudero-Contreras A, Pérez-Sánchez C. Lopez-Pedrera C, et al. Int J Mol Sci. 2020 Nov 28;21(23):9067. doi: 10.3390/ijms21239067. Int J Mol Sci. 2020. PMID: 33260629 Free PMC article. Review.
Proteomic approaches to evaluate protein S-nitrosylation in disease.
López-Sánchez LM, López-Pedrera C, Rodríguez-Ariza A. López-Sánchez LM, et al. Among authors: lopez pedrera c. Mass Spectrom Rev. 2014 Jan-Feb;33(1):7-20. doi: 10.1002/mas.21373. Epub 2013 Jun 15. Mass Spectrom Rev. 2014. PMID: 23775552 Review.
Proteomics in antiphospholipid syndrome: a review.
Cuadrado MJ, Aguirre MA, Barbarroja N, Khamashta MA, Lopez-Pedrera Ch. Cuadrado MJ, et al. Among authors: lopez pedrera ch. Lupus. 2010 Apr;19(4):385-8. doi: 10.1177/0961203309360986. Lupus. 2010. PMID: 20353974 Review.
Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses.
Pérez-Sánchez L, Patiño-Trives AM, Aguirre-Zamorano MÁ, Luque-Tévar M, Ábalos-Aguilera MC, Arias-de la Rosa I, Seguí P, Velasco-Gimena F, Barbarroja N, Escudero-Contreras A, Collantes-Estévez E, Pérez-Sánchez C, López-Pedrera C. Pérez-Sánchez L, et al. Among authors: lopez pedrera c. Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):865-877. doi: 10.1161/ATVBAHA.120.315346. Epub 2020 Dec 24. Arterioscler Thromb Vasc Biol. 2021. PMID: 33356391 Free article.
VEGF targeted therapy in acute myeloid leukemia.
Rodriguez-Ariza A, Lopez-Pedrera C, Aranda E, Barbarroja N. Rodriguez-Ariza A, et al. Among authors: lopez pedrera c. Crit Rev Oncol Hematol. 2011 Nov;80(2):241-56. doi: 10.1016/j.critrevonc.2010.09.009. Epub 2010 Oct 29. Crit Rev Oncol Hematol. 2011. PMID: 21035354 Review.
100 results